Emini Veseli, BesaVan Wielendaele, PieterDelibegovic, MirelaMartinet, WimDe Meyer, Guido R. Y.2021-06-032021-06-032021-05-31Emini Veseli, B, Van Wielendaele, P, Delibegovic, M, Martinet, W & De Meyer, G R Y 2021, 'The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition', International Journal of Molecular Sciences, vol. 22, no. 11, e5970. https://doi.org/10.3390/ijms221159701422-0067Jisc: 872f07a9c53f47089b11cdae02ed5601ORCID: /0000-0001-6193-3152/work/160847593https://hdl.handle.net/2164/16622Funding: This study was funded by the University of Antwerp (BOF project ID 29068, 40183 and iBOF project ID 21-053). Besa Emini Veseli is a PhD fellow of the Horizon 2020 program of the Eu-ropean Union - Marie Skłodowska-Curie Actions, Innovative Training Networks (ITN), Call: H2020-MSCA-ITN-2015, NUMBER—675527—MOGLYNET. Data Availability Statement: The data presented in this study are available on request from the corresponding author. Acknowledgments: The authors thank Mandy Vermont for excellent technical support and Anne-Marie Lambeir for scientific advice. The authors are grateful to Bronwen Martin for critical reading of the manuscript.152965918engSubstantive connection via eligible employment contractAZ PFKFB3 67PFKFB3endothelial cellsangiogenesisR MedicineEuropean Commission675527RJournal article10.3390/ijms221159702211